English   español  

Browsing by Author Fernández, Luis Ángel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
RightsPreviewIssue DateTitleAuthor(s)Type
openAccessbcr3585.pdf.jpg13-Dec-2013A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasisVan Impe, Katrien; Bethuyne, Jonas; Cool, Steven; Impens, Francis; Ruano-Gallego, David; De Wever, Olivier; Vanloo, Berlinda; Van Troys, Marleen; Lambein, Kathleen; Boucherie, Ciska; Martens, Evelien; Zwaenepoel, Olivier; Hassanzadeh-Ghassabeh, Gholamreza; Vandekerckhove, Joël; Gevaert, Kris; Fernández, Luis Ángel; Sanders, Niek N; Gettemans, Janartículo
openAccessAnalyzing the role of periplasmic factors.pdf.jpg2015Analyzing the role of periplasmic folding factors in the biogenesis of OMPs and members of the type V secretion systemBodelón, Gustavo; Marín, Elvira; Fernández, Luis Ángelcapítulo de libro
openAccessAttaching and effacing AE lesion formation....pdf.jpgOct-2017Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors.Cepeda-Molero, Massiel; Berger, Cedric N.; Walsham, Alistair D. S.; Ellis, Samuel J.; Wemyss-Holden, Simon; Schüller, Stephanie; Frankel, Gad; Fernández, Luis Ángelartículo
closedAccessaccesoRestringido.pdf.jpg2007Conjugative transfer can be inhibited by blocking relaxase activity within recipient cells with intrabodiesGarcillán-Barcia, M. Pilar; Jurado, Paola; González-Pérez, Blanca; Moncalián, Gabriel ; Fernández, Luis Ángel; Cruz, Fernando de la artículo
openAccessjournal.pone.0015227.pdf.jpg2010Direct Injection of Functional Single-Domain Antibodies from E. coli into Human CellsBlanco Toribio, Ana; Muyldermans, Serge; Frankel, Gad; Fernández, Luis Ángelartículo
openAccessCOBIOT-D-15-00008R1.pdf.jpgDec-2015Engineered bacteria as therapeutic agentsPiñero-Lambea, C.; Ruano Gallego, D.; Fernández, Luis Ángelartículo
openAccessEngineering the controlled assembly of filamentous injectisomes in E. coli....pdf.jpgSep-2015Engineering the Controlled Assembly of Filamentous Injectisomes in E. coli K‑12 for Protein Translocation into Mammalian CellsRuano-Gallego, David; Álvarez, Beatriz; Fernández, Luis Ángelartículo
openAccessEscherichia coli surface display....pdf.jpgNov-2017Escherichia coli surface display for the selection of nanobodies.Salema, Valencio; Fernández, Luis Ángelartículo
FEMSREV final.pdf.jpg23-Jul-2012Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologiesBodelón, Gustavo; Palomino, Carmen ; Fernández, Luis Ángelartículo
openAccessJurado et al. JBIOTECH.pdf.jpg31-Jul-2012Production and characterization of a recombinant single-chain antibody (scFv) for tracing the σ54 factor of Pseudomonas putidaJurado, Paola; Fernández, Luis Ángel; Lorenzo, Víctor deartículo
openAccessScreening and purification of nanobodies.pdf.jpgMar-2019Screening and purification of nanobodies from E. coli culture supernatants using the hemolysin secretion systemRuano‑Gallego, David; Fraile, Sofía; Gutierrez, Carlos; Fernández, Luis Ángelartículo
openAccessSynthetic consortia of nanobody-coupled and....pdf.jpgJan-2019Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities.Timmis, Kenneth; Timmis, James Kenneth; Brüssow, Harald; Fernández, Luis Ángelartículo